Patent · US Active

Quinolin-2-one derivatives

US11174241B2 · kind B2 · utility

0Cited by

1References

8Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Dieter Dorsch · Ober-Ramstadt, DE
Mathilde Muzerelle · Martigny, CH
Lars Burgdorf · Frankfurt am Main, DE
Margarita Wucherer-Plietker · Messel, DE
Paul Czodrowski · Friedberg, DE
Christina Esdar · Darmstadt, DE
Christos Tsaklakidis · Weinheim, DE

Key dates

Filing date	Feb 20, 2020
Grant date	Nov 16, 2021
Priority date	—
Expiry date	Feb 20, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D498/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of the formula I in which X1, X2, X3, X4, R1, R2, R3, Q and Y have the meanings indicated in Claim 1, are inhibitors of c-Kit kinase, and can be employed for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.